Interferon therapy shows acceptable safety in hepatitis B cirrhosis (IMAGE)
Caption
In patients with compensated cirrhosis, pegylated interferon-alpha (Peg-IFN-α) therapy demonstrated a comparable safety profile to nucleos(t)ide analog therapy, with no increase in decompensation or treatment-related hospitalizations.
Credit
SELF Magazine from Openverse Image source link: https://openverse.org/image/d39ad79c-807f-4cff-8919-d39c6fd81a8c?q=vaccination&p=62
Usage Restrictions
Credit must be given to the creator.
License
CC BY